TRAF6 and chronic myelogenous leukemia, BCR-ABL1 positive: GCA promoted TRAF6 ubiquitination ligase allowing ubiquitination of ULK1 lys63, and the result of this ubiquitination activated autophagy in CML cells, which modulated CML resistance to imatinib (Han et al., 2019).